en
James Davies

Cracked: Why Psychiatry is Doing More Harm Than Good

Giv mig besked når bogen er tilgængelig
Denne bog er ikke tilgængelig i streaming pt. men du kan uploade din egen epub- eller fb2-fil og læse den sammen med dine andre bøger på Bookmate. Hvordan overfører jeg en bog?
Why is psychiatry such big business? Why are so many psychiatric drugs prescribed — 47 million antidepressant prescriptions in the UK alone last year — and why, without solid scientific justification, has the number of mental disorders risen from 106 in 1952 to 374 today?
The everyday sufferings and setbacks of life are now 'medicalised' into illnesses that require treatment — usually with highly profitable drugs. Psychological therapist James Davies uses his insider knowledge to illustrate for a general readership how psychiatry has put riches and medical status above patients' well-being. The charge sheet is damning: negative drug trials routinely buried; antidepressants that work no better than placebos; research regularly manipulated to produce positive results; doctors, seduced by huge pharmaceutical rewards, creating more disorders and prescribing more pills; and ethical, scientific and treatment flaws unscrupulously concealed by mass-marketing.
Cracked reveals for the first time the true human cost of an industry that, in the name of helping others, has actually been helping itself.
Denne bog er ikke tilgængelig i øjeblikket
347 trykte sider
Copyrightindehaver
Bookwire
Oprindeligt udgivet
2013
Udgivelsesår
2013
Har du allerede læst den? Hvad synes du om den?
👍👎

Citater

  • Aniehar citeretsidste år
    Was this just an isolated example, or is it quite representative?
  • Aniehar citeretsidste år
    In other words, despite the damning research about antidepressant efficacy, and despite the NICE recommendations that we pull back on antidepressant use, continued regulatory approval has allowed prescriptions to just keep going up and up. Of course, this raises uncomfortable questions regarding the precise relationship between the regulatory agencies and the pharmaceutical industry. Do the agencies have an incentive to set the bar so low?
  • Aniehar citeretsidste år
    Given the results of studies outlined above, why do the regulatory agencies that evaluate antidepressants continue to approve these drugs for public use? Well, the key to answering this question is to realise that the regulatory agencies do not take into account the results of negative trials when deciding whether to approve an antidepressant.

På boghylderne

fb2epub
Træk og slip dine filer (ikke mere end 5 ad gangen)